Noida, UP -- (SBWire) -- 08/02/2010 -- As per our new research report “Global Protein Therapeutics Market Analysis”, the global insulin market will witness fast recovery in 2010 after the global financial turmoil. With the increasing number of diabetic patients every year and rising demand from emerging markets like India, China and Russia, it is expected that the global insulin market will grow at a CAGR of around 15% during 2010-2013. Further, the launch of new, painless and convenient methods of insulin delivery, such as oral insulin delivery, will certainly fuel growth in the industry in coming years.
We have also done thorough research and prudent analysis of the global protein therapeutics market and identified some critical factors acting as a catalyst for the industry current and future growth outlook. The report reveals that increase in the health insurance industry will renew interests of investors in the therapeutics market at the global level. Moreover, the rising incidence of lifestyle and chronic diseases such as diabetes, cancer, arthritis, etc. will give impetus to the market in coming years.
The report also studies the global protein therapeutics market to give an insight into its various segments, including Monoclonal Antibodies, Erythropoietins, Insulin, Interferon, Human Growth Hormone, Blood Clotting Factor, Granulocyte Colony Stimulating Factor and Follicle Stimulating Hormone. The comprehensive market analysis reveals that monoclonal antibodies currently holds the highest share, but the insulin segment will post rapid growth in future.
"Global Protein Therapeutics Market Analysis" provides thorough research and rational analysis along with reliable statistics of the global protein therapeutics industry.
The report incorporates extensive information of the traditional markets and emerging technologies. It also gives an insight into the prevailing trends at the regional protein therapeutics markets across the globe. Analysis and statistics regarding market size, growth, share, segmentation and geographic distribution have been thoroughly studied in the report to give a comprehensive view of the global protein therapeutics market. The report has thoroughly examined the current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM557.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
Global Insulin Market Set for Stupendous Upsurge
With the increasing number of diabetic patients and rising insulin demand from the emerging markets, the global insulin market will grow at a CAGR of 15% during 2010-2013, says RNCOS in its latest research study.